PetMeds narrows Q4 loss despite ongoing revenue decline
While lower prescription medication sales continued to pressure revenue, the American online pet pharmaceutical firm reduced its quarterly loss.
PetMeds reported $42.8 million (€37.2M) in revenue for the fourth quarter (Q4) of fiscal year (FY) 2026, ended 31 March.
Although it was a 5.4% increase from the previous qua…
Did you think it would be this easy? Nope! Just register. It’s free! Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut cursus turpis vel cursus ullamcorper. Sed ante mi, finibus eget porttitor a, tincidunt ac dolor. Vivamus ornare semper lorem, consequat commodo lectus elementum vitae. Cras id mattis urna. Donec rutrum dignissim lacinia. Duis ultricies sapien at ipsum tincidunt.
Sed in iaculis elit, sit amet convallis felis. Pellentesque non justo lectus. Donec sollicitudin lorem in sapien euismod varius at vitae mi. Maecenas ut elit ac risus consectetur vulputate. Praesent vel orci ante. Curabitur egestas dapibus nisi ac laoreet. Nullam a lacinia libero, non fringilla nisl.
You’re out of free articles,
register for unlimited access
Share this story:
One click prioritizes GlobalPETS in your search results and AI answers.
